Rabia Moukrad
Primary Care · Omaha, NENPI 1962048314
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AstraZeneca at 27.7% of the total. Reporting peaked in 2021 at $3,077 and has fallen 93.3% since, to $206 in 2025. Among primary care clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $29.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$781
- Johnson & Johnson$715
- AbbVie$630
- Bayer$453
- Otsuka America Pharmaceutical, Inc.$266
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,95298%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $1,679 |
| Novo Nordisk | 25 | $781 |
| Johnson & Johnson | 19 | $715 |
| AbbVie | 38 | $630 |
| Bayer | 16 | $453 |
| Otsuka America Pharmaceutical, Inc. | 11 | $266 |
| Lilly USA, LLC | 16 | $215 |
| Mannkind Corporation | 2 | $186 |
| Pfizer | 11 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $116 |
| Novartis | 4 | $94 |
| GSK | 1 | $93 |
| Collegium Pharmaceutical, Inc. | 6 | $92 |
| Amgen | 6 | $86 |
| Abiomed | 1 | $84 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| Amarin Pharma, Inc. | 3 | $56 |
| Janssen Scientific Affairs, LLC | 1 | $51 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Zealand Pharma US, Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Merck | 2 | $23 |
| Lundbeck LLC | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Boehringer Ingelheim | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Lifescan, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,051 in reported general payments places this provider in the 95th percentile of 65 primary care providers in Nebraska.
Other primary care in Omaha
- Jenna KoppOmaha$141K
- Alexis BarbosaOmaha$7K
- Keri DillonOmaha$2K
- Joseph AnthoneOmaha$2K
- Julie HuttonOmaha$2K
- Michelle PlacekOmaha$1K
- Johnna FeikOmaha$970
- Rasila Soumana HamaOmaha$732
- Tiffany BartekOmaha$643
- Nichole ThiesOmaha$628
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.